title: Reduction of the vein graft occlusion rate after coronary artery bypass surgery by treatment with a thromboxane receptor antagonist.
abstract: The early occlusion rate of vein grafts after coronary artery bypass surgery was reduced to 3.1% by treatment with a selective thromboxane receptor antagonist. The increased bleeding tendency caused by the substance led to a non-significant increase in blood transfusions.
authors.affiliation: Herz- und Gefässklinik, Bad Neustadt/Saale.
authors.forename: R W
authors.initials: RW
authors.lastname: Hacker
authors.forename: M
authors.initials: M
authors.lastname: Torka
authors.forename: I
authors.initials: I
authors.lastname: Yükseltan
authors.forename: V
authors.initials: V
authors.lastname: Pohlmann
authors.forename: P
authors.initials: P
authors.lastname: Meier
authors.forename: T
authors.initials: T
authors.lastname: Zimmermann
authors.forename: H
authors.initials: H
authors.lastname: Etti
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001026:Coronary Artery Bypass; D004311:Double-Blind Method; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D011982:Receptors, Prostaglandin / Q000378:metabolism; D017482:Receptors, Thromboxane; D013449:Sulfonamides / Q000627:therapeutic use
chemical_list: D000889:Anti-Arrhythmia Agents; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; D013449:Sulfonamides; C040624:sulotroban